Coya Therapeutics develops biologic treatments that aim to restore regulatory T cell function for patients with serious diseases. It last closed at $2.95 on Nov 20, down 1.01% on the day. The next earnings report for COYA is expected around Mon, Mar 15, 2027. For the quarter ended Sep 2026, COYA reported EPS of -$0.45 on revenue of $234,134, with revenue down 93.4% from a year ago. Over its last 8 reports the stock moved an average of 3.2% the session after earnings.
AI Auto Pilots
Is COYA in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold COYA.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on COYAStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
COYA · as of the Nov 20 close · updated each morning
Downtrend, nearing oversold
The stock is 12% below its 20 day and 40% below its 50 day average. It is 54% below its 200 day average, so the longer trend is down. Momentum is fading (RSI 33), near oversold. The nearest support is the Pivot S1 at $2.86, and the nearest resistance the Pivot at $2.99.
Short trendBearish
Long trendBearish
MomentumFading
StretchNear oversold
VolatilityHigh, 10.0%/day
Key levels
$6.6252 week high+124.4%
$4.53200 day average+53.6%
$4.42100 day average+49.8%
$4.1450 day average+40.3%
$3.47Swing high (Nov 10)+17.6%
$3.3020 day average+11.9%
$3.07Pivot R1+4.1%
$2.99Pivot+1.4%
$2.95Last close
$2.86Pivot S1−3.1%
$2.7252 week low−7.8%
$2.72Swing low (Nov 5)−7.8%
Indicators
RSI (14)
32.89
Weak, oversold below 30
Neutral
MACD
-0.33
Above its signal line
Bullish
Stochastic
26.7
Middle of its range
Neutral
ADX (14)
27.8
Trending down
Williams %R
-69.3
Oversold below −80, overbought above −20
Neutral
CCI (20)
-71.7
Oversold below −100, overbought above 100
Neutral
Rate of change
−1.3%
Change over 10 sessions
Bearish
ATR (14)
$0.30
Typical daily range, 10.0% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Downtrend, nearing oversold
Short trendBearish
Long trendBearish
MomentumWeak
StretchNear oversold
VolatilityNormal, 21.5%/day
Key levels
$6.6252 week high+124.4%
$4.53200 day average+53.6%
$4.42100 day average+49.8%
$4.1450 day average+40.3%
$3.47Swing high (Nov 10)+17.6%
$3.3020 day average+11.9%
$3.07Pivot R1+4.1%
$2.99Pivot+1.4%
$2.95Last close
$2.86Pivot S1−3.1%
$2.7252 week low−7.8%
$2.72Swing low (Nov 5)−7.8%
Indicators
RSI (14)
33.58
Weak, oversold below 30
Neutral
MACD
-0.41
Below its signal line
Bearish
Stochastic
11.5
Near the bottom of its range
Oversold
ADX (14)
19.4
No clear trend
Williams %R
-91.3
Oversold below −80, overbought above −20
Oversold
CCI (20)
-182.8
Oversold below −100, overbought above 100
Oversold
Rate of change
−32.6%
Change over 10 sessions
Bearish
ATR (14)
$0.63
Typical daily range, 21.5% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for COYA
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how COYA did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow COYA usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for COYAHow many large options trades hit COYA, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in COYA in the last 90 days.
From SEC Form 4 filings by COYA's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether COYA is in one of them and how their past COYA trades turned out.
Coya Therapeutics is a biotechnology company based in Houston, Texas. It is developing treatments that aim to restore the function of regulatory T cells, immune cells that help keep inflammation in check. Its lead candidate, COYA 302, is in clinical testing for amyotrophic lateral sclerosis and is also planned for frontotemporal dementia. The company's therapies are intended for patients with neurodegenerative, autoimmune and metabolic diseases.